RIV-1061-IR

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRIV-1061-IR
Drug Alias NameRIV-1061RIV-1061-IR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRevivo Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRevivo Therapeutics
Inactive CompaniesN/A
Active IndicationsCognition DisordersAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A